Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sunshine Biopharma Inc.

1.29
+0.04003.20%
Pre-market: 1.18-0.1100-8.53%07:41 EDT
Volume:11.72M
Turnover:17.38M
Market Cap:5.03M
PE:-0.18
High:1.59
Open:1.50
Low:1.21
Close:1.25
Loading ...

Company Profile

Company Name:
Sunshine Biopharma Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
52
Office Location:
333 Las Olas Way,CU4 Suite 433,Fort Lauderdale,Florida,United States
Zip Code:
33301
Fax:
- -
Introduction:
Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine Biopharma, Inc. is based in Fort Lauderdale, Florida.

Directors

Name
Position
Steve N. Slilaty
President, Chief Executive Officer and Chairman
Abderrazzak Merzouki
Chief Operating Officer and Director
Andrew Keller
Independent Director
David Natan
Independent Director
Rabi Kiderchah
Independent Director

Shareholders

Name
Position
Steve N. Slilaty
President, Chief Executive Officer and Chairman
Abderrazzak Merzouki
Chief Operating Officer and Director
Camille Sebaaly
Chief Financial Officer and Secretary